The rising interest in GLP-1 agonists for diabetes has sparked a debate about formats: transdermal systems versus pills . Traditionally , GLP-1 therapies were solely available in tablet form, but the https://laytnhrzl997625.blogoscience.com/47650135/glp-1-transdermal-delivery-systems-vs-pills-what-best-for-individuals